Typical guidance
Common supplemental study range: 1–2 g/day combined EPA + DHA.
MODERN BIO / BRAIN & COGNITION / SUPPLEMENT
Moderate evidenceOmega-3 EPA/DHA
Most useful when fatty-fish intake is low; quality and dose matter.
This page is a practical starting point—not a diagnosis or personalized prescription. The useful dose depends on the outcome, the person and the quality of the intervention.
01TYPESupplement
02TYPICAL SERVING / DOSECommon supplemental range: 1–2 g/day combined EPA + DHA
03TIMINGWith food, divided if preferred
04TRIAL LENGTH8–12 weeks before reassessing
HOW TO USE THIS PAGE
Decide whether omega-3 epa/dha deserves a real trial.
- 01Confirm the fit
Connect the intervention to a specific brain & cognition outcome and review the evidence boundary.
- 02Set the protocol
Define amount, timing, quality standard and a realistic trial length before starting.
- 03Track one useful signal
Choose the measure that will tell you to continue, adjust or stop.
RECOMMENDED RANGES
Men and women may need different context.
We only show a different amount when physiology, dietary requirements or clinical evidence supports it. Otherwise, we say the range is the same.Typical guidance
Common supplemental study range: 1–2 g/day combined EPA + DHA; pregnancy changes product-quality priorities.
Important context: Diet, cardiovascular risk, bleeding risk and treatment goal determine the appropriate amount.
WHAT IT MAY HELP WITH
Why people use it
Most useful when fatty-fish intake is low; quality and dose matter. Its relevance here is specifically connected to brain & cognition. Outcomes can differ when the same intervention is used for another purpose.
Moderate evidence
Promising human evidence exists, but studies, populations or results have meaningful limitations.
SERVING & PROTOCOL
How it is typically used
Common supplemental range: 1–2 g/day combined EPA + DHA
Prioritize fatty fish when appropriate and verify third-party testing and oxidation control.
- Timing
- With food, divided if preferred
- How long to assess
- 8–12 weeks before reassessing
QUALITY CHECK
What to look for
- A form, device, provider or protocol that matches the evidence—not just the marketing name.
- Transparent labeling, realistic claims and independent quality verification where applicable.
- A measurable reason to use it and a predefined way to judge whether it is helping.
- No hidden proprietary blend or pressure to replace proven medical care.
SAFETY & INTERACTIONS
What to know first
Review blood thinners, bleeding disorders and high-dose use with a clinician.
Stop and reassessDiscontinue and seek appropriate care for a severe reaction, fainting, chest symptoms, breathing difficulty, neurological changes or rapidly worsening symptoms.
SCIENTIFIC EVIDENCE
Read the data yourself.
These high-level sources establish the scientific context for brain & cognition. The live PubMed link narrows the literature to omega-3 epa/dha.01Commission evidence review · 2024
Dementia prevention, intervention, and care: 2024 Lancet Commission
Synthesizes modifiable dementia risks across the life course and estimates that addressing identified risk factors could prevent or delay a substantial share of cases.
Open scientific source ↗02AHA scientific statement · 2022
Life's Essential 8
Defines eight measurable behaviors and health factors for cardiovascular health—an important foundation for vascular brain health.
Open scientific source ↗LIVENATIONAL LIBRARY OF MEDICINE
Search Omega-3 EPA/DHA on PubMed
See the current indexed biomedical literature, including newer trials and reviews added after this page was published.
Open live PubMed search ↗Research quality is not determined by citation count alone. We consider design, sample size, controls, consistency, relevance, conflicts and whether the outcome was clinically meaningful.
MODERN BIO SELECT
The best option—regardless of commission.
We do not sell the top placement. Every winner must earn it through evidence, quality, safety, transparency and real-world value.PRODUCT / SERVICE PICKREVIEW IN PROGRESS
Best Omega-3 EPA/DHA product
We are comparing formulation, clinically relevant serving, contaminant testing, label transparency, value and manufacturer quality before naming a winner.
Get notified when selected →PROVIDER PICKVETTING IN PROGRESS
Best professional guidance
Our provider directory will prioritize credentialed clinicians and registered dietitians who evaluate the full picture before recommending a supplement.
Join the provider shortlist →What a winner must prove01 Third-party identity and contaminant testing02 A transparent, evidence-aligned serving03 No proprietary blend or inflated claims
NEXT STEP